IllinoisHB4953104th General Assembly (2025–2026)HouseWALLET

DRUG DISTRIBUTION RESTRICTIONS

Sponsored By: Sponsor information unavailable

Became Law

Summary

Amends the Wholesale Drug Distribution Licensing Act. In provisions concerning restrictions on transactions, provides that prescription drugs furnished by a manufacturer or wholesale distributor licensed under the Act may be delivered only to the business address of a licensee registered with the Department of Financial and Professional Regulation, to the premises listed on a license, or, if the Department has received notice that the licensee has authorized a health care entity to receive the prescription drugs, to the address of a health care entity (instead of only to the premises listed on the license). Provides that "health care entity" means an entity where medical, dental, or veterinary services are provided by a licensed practitioner and where the licensed practitioner is responsible for the receipt, storage, and use of drugs.

health care licensesassignmentslicensed activities

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

Analyzed Economic Effects

3 provisions identified: 1 benefits, 0 costs, 2 mixed.

Tighter checks on drug deliveries

Manufacturers and wholesale distributors must sell prescription drugs only to state‑licensed buyers. If the buyer is unfamiliar, they must confirm the buyer’s license with the state before shipping. Deliveries are limited to a licensee’s business address or licensed premises, or to a health care entity the Department knows is authorized. Pickup at a manufacturer’s site is allowed only to meet a specific patient’s immediate need, with identity and authority confirmed. Controlled substances must go only to registered business or professional locations. Hospital pharmacies must have a pharmacist or authorized staff sign for deliveries and report any mismatch by the next business day. A health care entity means a place where licensed practitioners provide care and are responsible for the drugs. These rules remain in effect until January 1, 2028.

Safer handling of returned drugs

Wholesale distributors may send expired, damaged, recalled, or other non‑saleable drugs only to the original manufacturer or a third‑party returns processor. Licensees and pharmacies must keep returns secure so counterfeit or adulterated drugs do not enter the supply chain. State pedigree paperwork does not apply to returns or exchanges that FDA guidance exempts. These rules remain in effect until January 1, 2028.

Tighter controls on drug purchase accounts

Manufacturers and wholesalers may accept payment or set up a drug purchase account only from the license owner, CEO, or CFO named on the license. Any account must be in the licensee’s name. A pharmacy or chain pharmacy warehouse may still receive drugs when payment runs through its contracted manufacturer or distributor. These rules remain in effect until January 1, 2028.

Sponsors & Cosponsors

Sponsors

There is no primary sponsor on record.

Cosponsors

  • Cristina Castro

    Affiliation unavailable

  • Kimberly A. Lightford

    Affiliation unavailable

  • Laura Ellman

    Affiliation unavailable

  • Martha Deuter

    Affiliation unavailable

  • Natalie A. Manley

    Affiliation unavailable

  • Rick Ryan

    Affiliation unavailable

Roll Call Votes

All Roll Calls

Yes: 201 • No: 0

Senate vote 5/28/2026

Third Reading - Passed;

Yes: 59 • No: 0

Senate vote 5/20/2026

Do Pass Licensed Activities;

Yes: 6 • No: 0

House vote 4/8/2026

Third Reading - Short Debate - Passed

Yes: 109 • No: 0

House vote 3/25/2026

House Floor Amendment No. 2 Recommends Be Adopted Health Care Licenses Committee;

Yes: 14 • No: 0

House vote 2/25/2026

Do Pass / Short Debate Health Care Licenses Committee;

Yes: 13 • No: 0

Actions Timeline

  1. Public Act . . . . . . . . . 104-0781

    8/7/2026House
  2. Effective Date January 1, 2027

    8/7/2026House
  3. Governor Approved

    8/7/2026House
  4. Sent to the Governor

    6/26/2026House
  5. Added as Alternate Co-Sponsor Sen. Cristina Castro

    5/30/2026Senate
  6. Added as Alternate Co-Sponsor Sen. Kimberly A. Lightford

    5/28/2026Senate
  7. Passed Both Houses

    5/28/2026House
  8. Third Reading - Passed; 059-000-000

    5/28/2026Senate
  9. Rule 2-10 Third Reading Deadline Established As May 31, 2026

    5/22/2026Senate
  10. Placed on Calendar Order of 3rd Reading May 25, 2026

    5/21/2026Senate
  11. Second Reading

    5/21/2026Senate
  12. Placed on Calendar Order of 2nd Reading May 21, 2026

    5/20/2026Senate
  13. Do Pass Licensed Activities; 006-000-000

    5/20/2026Senate
  14. Rule 2-10 Committee Deadline Established As May 22, 2026

    5/15/2026Senate
  15. Assigned to Licensed Activities

    5/12/2026Senate
  16. Rule 2-10 Committee Deadline Established As May 15, 2026

    5/12/2026Senate
  17. Referred to Assignments

    4/10/2026Senate
  18. First Reading

    4/10/2026Senate
  19. Chief Senate Sponsor Sen. Laura Ellman

    4/10/2026Senate
  20. Placed on Calendar Order of First Reading

    4/10/2026Senate
  21. Arrive in Senate

    4/10/2026Senate
  22. Third Reading - Short Debate - Passed 109-000-000

    4/8/2026House
  23. Placed on Calendar Order of 3rd Reading - Short Debate

    4/7/2026House
  24. Second Reading - Short Debate

    4/7/2026House
  25. House Floor Amendment No. 2 Adopted

    4/7/2026House

Bill Text

  • Engrossed

  • Enrolled

  • House Amendment 1

  • House Amendment 2

  • Introduced

Related Bills

Back to State Legislation